Omeros Corp (OMER)

$15.06 0.29 (1.89%)

16:01 EDT OMER Stock Quote Delayed 30 Minutes

Volume:

Previous Close $15.06

Market Cap 727.29M

PE Ratio -10.39

EPS -1.45

Volume (Avg. Vol.) 341,486

Day's Range 15.00 - 15.87

52-Week Range 8.50 - 20.92

Dividend & Yield N/A (N/A)

OMER Stock Predictions, Articles, and Omeros Corp News

From InvestorPlace
From the Web

Best ETFs for 2018: Don’t Sweat This Quarter for the SBIO ETF

By Todd Shriber, InvestorPlace Contributor Sep 28, 2018

On a year-to-date basis, SBIO still looks good, up 14.30%, or 310 basis points better than the Nasdaq Biotechnology Index. Year-to-date, SBIO is also outpacing the equal-weight S&P Biotechnology Select Industry Index.

Omeros’ (OMER) Robust Sales Growth Make it a Buy at recent price of $11.24

By Portfolio Grader Feb 15, 2018

The a Buy rating for OMER is based on the Portfolio Grader stock evaluator. The methodology for investing incorporated in this analytical tool researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current Portfolio Grader recommendation on the shares has been in place for 7 months.

11 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Dec 9, 2016

The overall ratings of 11 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

7 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Oct 14, 2016

This week, 7 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

19 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Sep 2, 2016

This week, the overall grades of 19 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

16 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader Aug 26, 2016

This week, the overall grades of 16 Pharmaceuticals stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Compare Brokers